Karen A Licitra - Net Worth and Insider Trading
Karen A Licitra Net Worth
The estimated net worth of Karen A Licitra is at least $123,598 dollars as of 2024-05-22. Karen A Licitra is the Director of SI-BONE Inc and owns about 8,797 shares of SI-BONE Inc (SIBN) stock worth over $123,598. Details can be seen in Karen A Licitra's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karen A Licitra has not made any transactions after 2021-06-25 and currently still holds the listed stock(s).
Transaction Summary of Karen A Licitra
Karen A Licitra Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen A Licitra owns 2 companies in total, including AngioDynamics Inc (ANGO) , and SI-BONE Inc (SIBN) .
Click here to see the complete history of Karen A Licitra’s form 4 insider trades.
Insider Ownership Summary of Karen A Licitra
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANGO | AngioDynamics Inc | 2023-07-19 | director |
| SIBN | SI-BONE Inc | 2021-06-25 | director |
Karen A Licitra Latest Holdings Summary
Karen A Licitra currently owns a total of 1 stock. Karen A Licitra owns 8,797 shares of SI-BONE Inc (SIBN) as of June 25, 2021, with a value of $123,598.
Latest Holdings of Karen A Licitra
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SIBN | SI-BONE Inc | 2021-06-25 | 8,797 | 14.05 | 123,598 |
Holding Weightings of Karen A Licitra
Karen A Licitra Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen A Licitra has made a total of 1 transactions in SI-BONE Inc (SIBN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in SI-BONE Inc is the sale of 21,408 shares on June 25, 2021, which brought Karen A Licitra around $715,027.
Insider Trading History of Karen A Licitra
- 1
Karen A Licitra Trading Performance
Karen A Licitra Ownership Network
Karen A Licitra Owned Company Details
What does AngioDynamics Inc do?
Who are the key executives at AngioDynamics Inc?
Karen A Licitra is the director of AngioDynamics Inc. Other key executives at AngioDynamics Inc include director & President and CEO James C Clemmer , SVP/GM & VIT Scott Centea , and SVP Global Operations and R&D Dave Helsel .
AngioDynamics Inc (ANGO) Insider Trades Summary
Over the past 18 months, Karen A Licitra made no insider transaction in AngioDynamics Inc (ANGO). Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 10,000 shares made by James C Clemmer , and a net sale of 4,633 shares made by Dave Helsel .
In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 4,633 shares of AngioDynamics Inc (ANGO) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 5,367 shares.
AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.
AngioDynamics Inc Insider Transactions
Karen A Licitra Mailing Address
Above is the net worth, insider trading, and ownership report for Karen A Licitra. You might contact Karen A Licitra via mailing address: C/o Si-bone, Inc., 471 El Camino Real, Suite 101, Santa Clara Ca 95050.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
